Skip to main content
Clinical Trials/NCT07645521
NCT07645521CompletedNot Applicable

Effect of Bilateral Trans-nasal Sphenopalatine Ganglion Block on Emergence Agitation Following Functional Endoscopic Sinus Surgery: A Double-Blind Randomized Controlled Trial

Mansoura University1 site in 1 country100 target enrollmentStarted: January 5, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1

Study Overview

Brief Summary

This randomized double-blind controlled trial aims to evaluate whether bilateral trans-nasal sphenopalatine ganglion block (SPGB) using bupivacaine reduces the incidence of emergence agitation following Functional Endoscopic Sinus Surgery (FESS) compared with placebo. Secondary objectives include evaluation of postoperative pain, postoperative opioid consumption, hemodynamic parameters, postoperative nausea and vomiting, and adverse events.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

The study solution was prepared in identical syringes by a scrub nurse who was not involved in patient management, outcome assessment, data collection, or statistical analysis. Participants, the surgeon performing the block and surgery, the attending anesthesiologist, outcome assessors, investigators, and the statistician remained blinded to treatment allocation throughout the study.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18-65 years.
  • ASA physical status I-II.
  • Scheduled for elective FESS under general anesthesia.
  • Ability to provide informed consent.

Exclusion Criteria

  • ASA physical status III or higher.
  • Known allergy or contraindication to local anesthetics.
  • Coagulopathy or anticoagulant therapy.
  • Psychiatric illness or cognitive impairment affecting agitation assessment.
  • Chronic opioid use or substance abuse.
  • Pregnancy or lactation.
  • Revision nasal surgery or anatomical abnormalities preventing SPGB.
  • Intraoperative complications requiring deviation from the study protocol.

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials